Shiraki et al. used the heart and skeletal muscle-specific manganese superoxide dismutase (MnSOD) deficiency dilated cardiomyopathy mouse model and demonstrated that the amount of cardiac FA uptake and the CD36 content in the Empagliflozin group did not alter significantly compared to the model group (32). This evidence concerns the gene CD36 and dilated cardiomyopathy.